highly significantP = 0.005
However, significant reductions in HbA1c%, HbA1c mmol/mol (0.36% and 3.96 mmol/mol, both P ≤ 0.001) and systolic blood pressure (3.84 mmHg, P = 0.004) were seen at the 6-month follow-up. Association of step count change with inflammatory and clinical markers of T2DM and CVD An increase in daily step count was associated with a highly significant decrease in IL6 ( P = 0.005) which represented a 0.81 ng/L reduction per 1000 steps, equating to a 13% decrease.